Helping teams move from therapeutic concept to CRO-ready DNA designs, executable study plans, and decision-grade preclinical data.
Senior-level technical support before a company commits substantial money to DNA synthesis, vector production, CRO studies, or diligence decisions.
Focused support for early-stage teams that need senior technical judgment without immediately hiring full-time platform or preclinical leadership.
Early-stage biotech, gene therapy, genetic medicine, platform biology, and preclinical teams.
DNA design, promoter development, vector strategy, study design, CRO selection and management, and technical diligence.
Construct maps, study plans, CRO quote comparisons, data review memos, SOPs, and decision-gate recommendations.
Gene therapy; AAV, lentiviral, and CAR-T vector platforms; promoter/enhancer and regulatory element design; in vivo pharmacology; assay development; lab and project team leadership; translational strategy.
Hourly advisory, fixed-scope work package, capped hourly project, monthly retainer, or diligence sprint.
Industry and academic experience across molecular biology, viral vectors, preclinical development, CRO/CDMO execution, and portfolio decision support.
20+ years across molecular biology, virology, immunology, oncology, and neuroscience.
10+ years leading development of AAV platform for CNS gene therapy and lentiviral CAR-T platform at Novartis.
Project team leadership from target discovery through preclinical development.
Lab head with a record of building teams, platforms, and research capabilities from scratch.
Consulting support for startup biotech companies funded by major VC groups with focus on vector design, assay development, and study planning.
CRO/CDMO management, governance decision support, technical diligence, portfolio strategy, and IP generation.
Practical deliverables for teams preparing construct designs, CRO-facing studies, diligence reviews, or ongoing preclinical execution.
For companies needing plasmids, AAV/LVV constructs, promoter/enhancer designs, reporters, barcodes, or expression cassettes.
For teams preparing in vitro, in vivo, biodistribution, expression, potency, or exploratory pharmacology studies.
For small teams that know what they need but cannot manage execution.
For investors, company founders, or BD teams evaluating an asset.
For seed-stage companies without a full-time head of platform/preclinical.
Additional capability for evidence generation, prioritization, and data-analysis workflows.
Support for teams that need stronger construct logic, cleaner study design, better CRO scoping, or diligence-grade technical assessment before committing budget and timelines.
Diluks LLC - Scientific & Technical Consulting for Early-Stage Biotech
Available for hourly advisory, fixed-scope work packages, capped hourly projects, monthly retainers, diligence sprints, CRO-facing workstreams, and fractional scientific leadership.